These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38734742)

  • 41. Association between frailty and hepatic fibrosis in NAFLD among middle-aged and older adults: results from NHANES 2017-2020.
    Atabieke F; Li XJ; Aierken A; Li J; Zhang Y; Aizezi Y; Gao HL; Zhang ZQ
    Front Public Health; 2024; 12():1330221. PubMed ID: 38389936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel reliability criteria for controlled attenuation parameter assessments for non-invasive evaluation of hepatic steatosis.
    Semmler G; Wöran K; Scheiner B; Unger LW; Paternostro R; Stift J; Schwabl P; Bucsics T; Bauer D; Simbrunner B; Stättermayer AF; Pinter M; Trauner M; Reiberger T; Mandorfer M
    United European Gastroenterol J; 2020 Apr; 8(3):321-331. PubMed ID: 32213023
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The association between atherogenic index of plasma and metabolic dysfunction-associated fatty liver disease as detected by FibroScan.
    Wang A; Li J; Li L; Ding H; Yang N; Xu M
    Nutr Hosp; 2024 Apr; 41(2):384-392. PubMed ID: 38328923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The association between serum folate and ultrasound - defined hepatic steatosis.
    Chen X; Lu J; Xu Q; Chen B; Shen L
    Ann Med; 2023 Dec; 55(1):456-462. PubMed ID: 36647694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prevalence of alcoholic and nonalcoholic fatty liver disease in adolescents and young adults in the United States: analysis of the NHANES database.
    Alkhouri N; Almomani A; Le P; Payne JY; Asaad I; Sakkal C; Vos M; Noureddin M; Kumar P
    BMC Gastroenterol; 2022 Jul; 22(1):366. PubMed ID: 35907827
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension.
    Semmler G; Stift J; Scheiner B; Wöran K; Schwabl P; Paternostro R; Bucsics T; Stättermayer AF; Pinter M; Ferlitsch A; Trauner M; Reiberger T; Mandorfer M
    Dig Dis Sci; 2019 Dec; 64(12):3642-3651. PubMed ID: 31209721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Blood pressure, glycemic status and advanced liver fibrosis assessed by transient elastography in the general United States population.
    Ciardullo S; Monti T; Grassi G; Mancia G; Perseghin G
    J Hypertens; 2021 Aug; 39(8):1621-1627. PubMed ID: 33657584
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of the fat mass index with hepatic steatosis and fibrosis: evidence from NHANES 2017-2018.
    Liu L; Lin J; Yin M; Liu L; Gao J; Liu X; Zhu J; Wu A
    Sci Rep; 2024 Mar; 14(1):6943. PubMed ID: 38521854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.
    Alfadda AA; Sherbeeni SM; Alqutub AN; Aldosary AS; Aldaghri NM; Taylor-Robinson SD; Alqahtani SA; Gul R; Almaghamsi AM
    Saudi J Gastroenterol; 2022; 28(6):426-433. PubMed ID: 35645140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound.
    Carvalhana S; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Liver Int; 2014 Jul; 34(6):e111-7. PubMed ID: 24034415
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relevance of vitamin D on NAFLD and liver fibrosis detected by vibration controlled transient elastography in US adults: a cross-sectional analysis of NHANES 2017-2018.
    Ji Y; Wei CB; Gu W; Hou LL
    Ann Med; 2023 Dec; 55(1):2209335. PubMed ID: 37155562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship of liver stiffness and controlled attenuation parameter measured by transient elastography with diabetes mellitus in patients with chronic liver disease.
    Ahn JM; Paik YH; Kim SH; Lee JH; Cho JY; Sohn W; Gwak GY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    J Korean Med Sci; 2014 Aug; 29(8):1113-9. PubMed ID: 25120322
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Accuracy of steatosis and fibrosis NAFLD scores in relation to vibration controlled transient elastography: An NHANES analysis.
    Sourianarayanane A; McCullough AJ
    Clin Res Hepatol Gastroenterol; 2022; 46(7):101997. PubMed ID: 35842111
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of serum uric acid with hepatic steatosis detected by controlled attenuation parameter in the United States population.
    Feng Y; Zheng S; Liu L; Yang Y
    Lipids Health Dis; 2023 Jun; 22(1):76. PubMed ID: 37340407
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic steatosis in people older and younger than fifty who are living with HIV and HIV-negative controls: A cross-sectional study nested within the POPPY cohort.
    Arenas-Pinto A; Bakewell N; Milinkovic A; Williams I; Vera J; Post FA; Anderson J; Beynon M; O'Brien A; Doyle N; Gilson R; Pett SL; Winston A; Sabin CA;
    HIV Med; 2024 Jan; 25(1):95-106. PubMed ID: 37670375
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low Liver Density Is Linked to Cardiovascular Comorbidity in COPD: An ECLIPSE Cohort Analysis.
    Viglino D; Martin M; Almeras N; Després JP; Coxson HO; Pépin JL; Vivodtzev I; Maltais F;
    Int J Chron Obstruct Pulmon Dis; 2019; 14():3053-3061. PubMed ID: 32099343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Performance of continuous controlled attenuation parameter and liver stiffness measurement by the novel SmartExam in metabolic dysfunction-associated steatotic liver disease.
    Song SJ; Nogami A; Liang LY; Yoneda M; Leung HHW; Nakajima A; Lai JCT; Wong GLH; Shu SST; Wong VWS; Yip TCF
    Liver Int; 2024 May; 44(5):1167-1175. PubMed ID: 38353063
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The association between non-alcoholic fatty liver disease and serum ferritin levels in American adults.
    Yang N; Lu Y; Cao L; Lu M
    J Clin Lab Anal; 2022 Feb; 36(2):e24225. PubMed ID: 34997649
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of controlled attenuation parameter for liver steatosis in patients with chronic hepatitis B.
    Wang CY; Lu W; Hu DS; Wang GD; Cheng XJ
    World J Gastroenterol; 2014 Aug; 20(30):10585-90. PubMed ID: 25132779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.